Foamix and Menlo Therapeutics to Merge, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications

The combined company will have a diversified portfolio including an approved product and three late-stage product candidates focused on dermatologic indications.